SCHEMBL6408930

SCHEMBL6408930

COc1ccccc1C(c1cccc2ccccc12)[C@](C#N)(Cc1ccccc1Cl)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
FABP4 P15090 2/20 0.39
FABP5 Q01469 2/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
CTSS P25774 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4662608 1.00 L3MBTL1 (0.42) L3MBTL1ESR1ESR2FABP4FABP5
SCHEMBL4661376 0.91 ESR1 (0.42) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4661269 0.88 L3MBTL1 (0.42) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL5686369 0.86 ESR1 (0.44) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4660129 0.86 ESR1 (0.44) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4661587 0.86 ESR1 (0.45) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4722949 0.84 ESR1 (0.42) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4766931 0.84 ESR1 (0.42) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL6433797 0.83 ESR1 (0.45) L3MBTL1ESR1ESR2FABP5MEN1
SCHEMBL4659952 0.83 ESR1 (0.45) L3MBTL1ESR1ESR2FABP5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 L3MBTL1 4004/4885ESR1 4557/4885ESR2 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.